Sm. Wildhirt et al., Expression of endomyocardial nitric oxide synthase and coronary endothelial function in human cardiac allografts, CIRCULATION, 104(12), 2001, pp. I336-I343
Citations number
24
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-Inducible nitric oxide synthase (iNOS) is expressed and is funct
ionally active in the presence of transplant arteriosclerosis. However, the
early involvement of iNOS in alterations of microvascular endothelial func
tion in the absence of preexisting lesions remains unclear; this informatio
n would be of prognostic value. We studied the course of iNOS mRNA expressi
on, transcardiac nitric oxide production, and their potential association w
ith microvascular coronary endothelial dysfunction in human cardiac allogra
fts.
Methods and Results-A total of 42 patients were studied at 1, 6, and 12 mon
ths after heart transplantation. Microvascular coronary flow velocity reser
ve (CFVR) was tested in an endothelium-dependent (acetylcholine) and -indep
endent manner (adenosine) using a Doppler flow wire. Endomyocardial iNOS ex
pression was determined by reverse transcription polymerase chain reaction.
iNOS protein and nitrotyrosine levels were detected by immunohistochemistr
y. Transcardiac plasma nitrite/nitrate (NOx) levels were measured by the Gr
iess reaction. CFVR was impaired in 26.1% of patients (n=11) at I month and
in 31% of patients (n=13) at 12 months after heart transplantation. Patien
ts who developed impaired CFVR in the first year showed a significant incre
ase in iNOS gene expression. Patients with impairment of CFVR I month after
heart transplantation had higher levels of iNOS mRNA than patients with a
normal CFVR. Patients with an initial impairment of CFVR who did not improv
e over time presented with significantly higher iNOS mRNA levels. iNOS prot
ein and nitrotyrosine were expressed in the endomyocardial vessels of patie
nts with impaired CFVR. Transcardiac NOx release was higher in patients wit
h impaired CFVR.
Conclusions-In human cardiac allografts, microvascular endothelial dysfunct
ion is associated with an enhanced endomyocardial iNOS mRNA expression and
higher transcardiac NOx production and is accompanied by the expression of
nitrotyrosine protein, suggesting peroxynitrite plays a role in the disease
process. The data from the present study suggest an important role for the
iNOS/nitric oxide pathway in the regulation of microvascular function in t
he absence of preexisting atherosclerotic lesions.